Latest news
SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTSciSparc Announces NeuroThera Labs Achieves Milestone in Quantum-Enabled Clinical Trial Data Analytics Platform - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 12:30:00 GMTSciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMTSciSparc subsidiary NeuroThera Labs’ quantum platform completes end-to-end hybrid workflow for clinical data analytics - BitgetBitget · Fri, 31 Jul 2026 07:00:00 GMTSciSparc: Subsidiary NeuroThera Labs Advances Its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 Company - MoomooMoomoo · Wed, 29 Jul 2026 12:32:00 GMTSciSparc's Quantum Workflow Evaluated on S&P 500 Company Platform - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTNeuroThera Labs Advances Its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 Company - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT